Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwNHL 2017 | Clinical trials, pathologies and developments in personalized medicine

Francesco d'Amore, Laurence de Leval, Philippe Gaulard and Richard Delarue • 18 Sep 2017
iwNHL 2017
Non-Hodgkin Lymphoma

Philippe Gaulard, MD, PhD, from the Henri-Mondor Hospital, Paris, France, Francesco D’Amore, MD, PhD, from the Aarhus University, Aarhus, Denmark, Richard Delarue, MD, from the Necker-Enfants Malades Hospital, Paris, France, discuss topics such as recent developments in molecular pathology, results of recent clinical trials, and novel opportunities in personalized medicines in lymphoma at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada.

More from Francesco d'Amore

7:22
Managing T-cell lymphomas in light of the updated WHO classification
Francesco d'Amore • 27 Sep 2019
iwNHL 2017: T-cell lymphomas, Hodgkin's lymphoma, immunotherapy and epigenetics
Francesco d'Amore et al. • 8 Sep 2017
6:49
Update of peripheral T-cell lymphoma treatment
Elaine Jaffe et al. • 5 Sep 2014
4:37
iwNHL 2015 roundtable: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma
Francesco d'Amore et al. • 3 Oct 2015

More from Laurence de Leval

Updates on the biology and treatment of T-cell lymphoma
Francine Foss et al. • 17 Oct 2023
12:31
T-cell lymphomas: murine models, in-situ treatments & screening for HTLV1
David Weinstock et al. • 16 Sep 2019
6:49
Update of peripheral T-cell lymphoma treatment
Elaine Jaffe et al. • 5 Sep 2014
4:37
iwNHL 2015 roundtable: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma
Francesco d'Amore et al. • 3 Oct 2015

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals